James R Meyers Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James R Meyers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James R Meyers. James R Meyers is a EVP Worldwide Commercial Ops in GILEAD SCIENCES INC ($GILD) and a SVP Comm Ops North America in GILEAD SCIENCES INC ($GILD) and a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and a Director in Arbutus Biopharma Corp ($TKMR) and a Director in CytomX Therapeutics, Inc. ($CTMX).
Address: GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY 94404 CA
Companies in which James R Meyers is an Insider
Arbutus Biopharma Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James R Meyers: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 01 2020
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James R Meyers: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James R Meyers: EVP Worldwide Commercial Ops, SVP Comm Ops North America
Holdings: 2,936 shares
Current Value: $214,710
Latest Transaction: Feb 23 2018
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James R Meyers: Director
Holdings: 23,200 shares
Current Value: $89,320
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James R Meyers
Sentiment: All, TKMR, CTMX, GILD, SGMO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
| Jun 19 2020 | CTMX | CytomX Therapeutic ... | Meyers James R | Director | Option Exercise | A | 8.35 | 20,000 | 167,000 | 20,000 | |
| Jun 01 2020 | TKMR | Arbutus Biopharma ... | Meyers James R | Director | Option Exercise | A | 2.16 | 22,000 | 47,520 | 22,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 10.46 | 15,000 | 156,900 | 15,000 | |
| May 20 2020 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Grant | A | 0.00 | 2,500 | 0 | 7,500 | 5 K to 7.5 K (+50.00 %) |
| Nov 26 2019 | SGMO | SANGAMO THERAPEUTI ... | Meyers James R | Director | Option Exercise | A | 9.81 | 30,000 | 294,300 | 30,000 |